REGENICS AS
Signals
- Driftsunderskudd 2024 Siste driftsresultat er negativt (−6,3 mill kr).
REGENICS AS is registered as a limited company in Oslo, Oslo with organisation number 982277086. The business is classified under technical testing and analysis (NACE 71.200). The company was incorporated in 2000 and has 5 registered employees. Registered share capital is NOK 16.3m, divided into 16305643 shares. The company's stated purpose is: “Forskning, utvikling og salg av produkter og teknologier innenfor stamcelleforskning og dertil hørende virksomhet.”. The most recent filed accounts, for the 2024 financial year, show NOK 2.3m in revenue and NOK −6.3m in operating profit.
Key figures · 2024
Financial health · 2024
Who owns REGENICS AS?
REGENICS AS has 20+ registered shareholders:
- ÍSLANDSBANKI HF. 38.1%
- LIFE CAPITOL AS 20.5%
- HELDRUP AS 15.7%
- HØGENIPA AS 4.7%
- CORNUCOPIA AS 3.9%
- INTENTO AS 3.4%
- CAPRA INVEST AS 2.2%
- WLH INVEST AS 1.8%
- RUNE NILSEN 1.5%
- PHILIPPE COLLAS 1.2%
- SOLVIK HOLDING AS 1.0%
- BRAKTOR INVEST AS 0.9%
- RUNHILD GAMMELSÆTER 0.8%
- MARKUS GRØNNESTAD HELDRUP 0.8%
- SIESTA INVEST AS 0.7%
- KOLLVEST AS 0.6%
- TVVT INVEST AS 0.5%
- GRY LØNNE ERIKSSON 0.4%
- JAN ALAN ALFHEIM 0.4%
- GREYSTON HOLDING AS 0.2%
Frequently asked questions about REGENICS AS
Who owns REGENICS AS?
ÍSLANDSBANKI HF. is the largest registered owner, with 38.1%.
What is the revenue of REGENICS AS?
REGENICS AS had revenue of NOK 2.3m in 2024.
Who is the general manager of REGENICS AS?
Jostein Grip is registered as general manager of REGENICS AS.
Where is REGENICS AS based?
REGENICS AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.